Citations

Clear

3030 citation(s) found for "Susan, M".

Pain Management in Four‐Limb Amputation: A Case Report
Warner, Matthew A. , Moeschler, Susan M. , Hoelzer, Bryan C. , Warner, Nafisseh S. , Warner, Matthew A

Mayo Clinic

Pain Practice | May 26, 2015 | Volume: 15 | Issue: 7 | Pages: No page available

10.1111/papr.12307 | PMID 26011696 Get It

AbstractAcute pain following amputation can be challenging to treat due to multiple underlying mechanisms and variable clinical responses to treatment. Furthermore, poorly controlled preoperative pain is a risk factor for developing chronic pain. Evidence suggests that epidural analgesia and peripheral nerve blockade may decrease the severity of residual limb pain and the prevalence of phantom pain after lower extremity amputation. We present the perioperative analgesic management of a patient with gangrene of the bilateral upper and lower extremities as a result of septic shock and prolonged vasopressor administration who underwent four‐limb amputation in a single procedure. A multimodal analgesic regimen was utilized, including titration of preoperative opioid and neuropathic pain agents, perioperative intravenous, epidural and peripheral nerve catheter infusions, and postoperative oral medication titration. More than 8 months postoperatively, the patient has satisfactory pain control with no evidence for phantom limb pain. To our knowledge, there have been no publications to date concerning analgesic regimens in four‐limb amputation.
Clinical Use of Pulse Wave Analysis: Proceedings From a Symposium Sponsored by North American Artery
Black, Henry R., Chirinos, Julio A. , Feig, Peter U., Ferdinand, Keith C. , Germain, Michael, Rosendorff, Clive , Steigerwalt, Susan, Stepanek, Jan A, Townsend, Raymond R. , Stepánek, Jan

Mayo Clinic

The Journal of Clinical Hypertension | May 23, 2015 | Volume: 17 | Issue: 7 | Pages: 503-513

10.1111/jch.12574 | PMID 26010834 Get It

The use of pulse wave analysis may guide the provider in making choices about blood pressure treatment in prehypertensive or hypertensive patients. However, there is little clinical guidance on how to interpret and use pulse wave analysis data in the management of these patients. A panel of clinical researchers and clinicians who study and clinically use pulse wave analysis was assembled to discuss strategies for using pulse wave analysis in the clinical encounter. This manuscript presents an approach to the clinical application of pulse waveform analysis, how to interpret central pressure waveforms, and how to use existing knowledge about the pharmacodynamic effect of antihypertensive drug classes in combination with brachial and central pressure profiles in clinical practice. The discussion was supplemented by case‐based examples provided by panel members, which the authors hope will provoke discussion on how to understand and incorporate pulse wave analysis into clinical practice.
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
Gustafson, Michael P. , Lin, Yi , Bleeker, Jonathan , Tollefson, Matthew K. , Crispen, Paul L. , Bulur, Peggy A. , Harrington, Susan M. , Laborde, Rebecca R., Gastineau, Dennis A. , Leibovich, Bradley C. , Cheville, John C. , Kwon, Eugene D., Dietz, Allan B. , Warad, Deepti , Dietz, Allan B , Lin, Yi

Mayo Clinic

Clinical Cancer Research | May 21, 2015 | Volume: 21 | Issue: 18 | Pages: 4224-4233

10.1158/1078-0432.ccr-15-0260 | PMID 25999436 Get It

Abstract Purpose: Immunotherapeutic strategies to treat patients with renal cell carcinoma (RCC) offer new opportunities for disease management. Further improvements to immunotherapy will require additional understanding of the host response to RCC development. Experimental Design: Using a novel approach to understanding the immune status of cancer patients, we previously showed that patients with a certain immune profile had decreased overall survival. Here, we examine in more detail the phenotypic changes in peripheral blood and the potential consequences of these changes in RCC patients. Results: We found that CD14+HLA-DRlo/neg monocytes were the most predominant phenotypic change in peripheral blood of RCC patients, elevated nearly 5-fold above the average levels measured in healthy volunteers. Intratumoral and peritumoral presence of CD14 cells was an independent prognostic factor for decreased survival in a cohort of 375 RCC patients. The amount of peripheral blood CD14+HLA-DRlo/neg monocytes was found to correlate with the intensity of CD14 staining in tumors, suggesting that the measurement of these cells in blood may be a suitable surrogate for monitoring patient prognosis. The interaction of monocytes and tumor cells triggers changes in both cell types with a loss of HLA-DR expression in monocytes, increases of monocyte survival factors such as GM-CSF in tumors, and increased production of angiogenic factors, including FGF2. Conclusions: Our results suggest a model of mutually beneficial interactions between tumor cells and monocytes that adversely affect patient outcome. Clin Cancer Res; 21(18); 4224–33. ©2015 AACR.
Spiritual Well-Being and Spiritual Practices in Elderly Depressed Psychiatric Inpatients
Piderman, Katherine M. , Stevens, Susanna R., Somers, Kristin J., Kronberg, Matthew T., Clark, Matthew M. , Rummans, Teresa A. , Lapid, Maria I. , Ryan, Susan

Mayo Clinic

Journal of Pastoral Care & Counseling: Advancing theory and professional practice through scholarly and reflective publicati | May 18, 2015 | Volume: 65 | Issue: 1 | Pages: 1-11

10.1177/154230501106500103 | PMID 22452149 Get It

This study's aims were to describe the spirituality of depressed elderly psychiatric inpatients and to examine associations among spirituality, depression, and quality of life (QOL). Forty-five persons participated. Most reported frequent, stable spiritual practices and experiencing spiritual comfort and guidance. Some reported spiritual distress and changes in spirituality. During hospitalization, participants demonstrated increased spiritual well-being (SWB) and peacefulness, and reduced hopelessness, worthlessness, and guilt. Positive associations were found between SWB and QOL and negative associations between SWB and depression.
Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
Kramer, Daniel B. , Mitchell, Susan L., Jones, Paul W. , Normand, Sharon‐Lise T. , Hayes, David L. , Reynolds, Matthew R. , Monteiro, João P.

Mayo Clinic

Journal of the American Heart Association | May 16, 2015 | Volume: 4 | Issue: 5 | Pages: No page available

10.1161/jaha.115.001775 | PMID 25979902 Get It

Background Physical activity data are collected automatically by implantable cardioverter‐defibrillators ( ICD s). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its relationship with survival has not been well studied. Methods and Results Patients enrolled in the Boston Scientific LATITUDE remote monitoring system from 2008 to 2012 with ICD s were eligible. Remote monitoring data were used to calculate mean daily activity at baseline (30 to 60 days after implantation), and longitudinally. Cox regression was used to examine the association between survival and increments of 30 minutes/day in both (1) mean baseline activity and (2) time‐varying activity, with both adjusted for demographic and device characteristics. A total of 98 437 patients were followed for a median of 2.2 years (mean age of 67.7±13.1 years; 71.7% male). Mean baseline daily activity was 107.5±66.2 minutes/day. The proportion of patients surviving after 4 years was significantly higher among those in the most versus least active quintile of mean baseline activity (90.5% vs. 50.0%; log‐rank P value, <0.001). Lower mean baseline activity (i.e., incremental difference of 30‐minutes/day) was independently associated with a higher risk of death (adjusted hazard ratio [ AHR ], 1.44; 95% confidence interval [ CI ], 1.427 to 1.462). Time‐varying activity was similarly associated with a higher risk of death ( AHR , 1.48; 95% CI , 1.451 to 1.508), indicating that a patient having 30 minutes per day less activity in a given month has a 48% increased hazard for death when compared to a similar patient in the same month. Conclusions Patient activity measured by ICD s strongly correlates with survival following ICD implantation.
Impact of Ibrutinib and Idelalisib on the Pharmaceutical Cost of Treating Chronic Lymphocytic Leukemia at the Individual and Societal Levels
Finnes, Heidi D. , Chaffee, Kari G. , Leis, José F., Chanan‐Khan, Asher , Call, Tim G., Rabe, Kari G. , Borah, Bijan J. , Chanan-Khan, Asher A., Shanafelt, Tait D. , Ding, Wei , Parikh, Sameer A. , Slager, Susan L. , Kay, Neil E. , Call, Timothy G.

Mayo Clinic

Journal of Oncology Practice | May 15, 2015 | Volume: 11 | Issue: 3 | Pages: 252-258

10.1200/jop.2014.002469 | PMID 25804983 Get It

Although ibrutinib and idelalisib are profound treatment advances, they will dramatically increase individual out-of-pocket and societal costs of caring for patients with CLL.
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Loh, Mignon L. , Brown, Patrick A. , Magoon, Daniel, Chen, Xuejun , Ahern, Charlotte H., Weigel, Brenda J. , Blaney, Susan M. , Reid, Joel M. , Tasian, Sarah K. , Rabin, Karen R. , Loh, Mignon L

Mayo Clinic

Pediatric Blood & Cancer | May 13, 2015 | Volume: 62 | Issue: 10 | Pages: 1717-1724

10.1002/pbc.25575 | PMID 25976292 Get It

Assessment of family history of substance abuse for preventive interventions with patients experiencing chronic pain: A quality improvement project
Pestka, Elizabeth L., Nash, Virginia , Evans, Michele M., Cronin, Joan B., Bee, Susan, King, Susan , Osborn, Kristine, Gehin, Jessica M. , Weis, Karen L. , Loukianova, Larissa L., Pestka, Elizabeth, Evans, Michele, Cronin, Joan, Gehin, Jessica, Weis, Karen, Loukianova, Larissa

Mayo Clinic

International Journal of Nursing Practice | May 12, 2015 | Volume: 22 | Issue: 2 | Pages: 121-128

10.1111/ijn.12400 | PMID 25963926 Get It

This quality improvement project demonstrates that RN Care Managers, in a chronic pain programme, can assess for a family history of substance abuse in 5–10 min. Information informs treatment based on specific high risk criteria. Benefits include heightened awareness of the genetic and environmental risks associated with a family history of substance abuse, an opportunity to participate in motivational interventions to prevent or minimize consequences of substance use disorders, and likely substantial overall health‐care cost savings.
Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium
Kane, Eleanor , Skibola, Christine F., Bracci, Paige M. , Costas, Laura , Smedby, Karin E. , Holly, Elizabeth A., Novak, Anne J. , Lightfoot, Tracy, Ansell, Stephen M. , Smith, Alex, Liebow, Mark , Melbye, Mads , Morton, Lindsay M. , Sanjosé, Sílvia de , Wang, Sophia , Zheng, Tongzhang, Roman, Eve , Smith, Alexandra , Cerhan, James R. , Maynadié, Marc , Slager, Susan L. , Zhang, Yawei , Kane, Eleanor , Morton, Lindsay M , Wang, Sophia S , Roman, Eve , Smith, Alexandra

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | May 11, 2015 | Volume: 24 | Issue: 7 | Pages: 1061-1070

10.1158/1055-9965.epi-14-1355 | PMID 25962811 Get It

Abstract Background: Excess adiposity has been associated with lymphomagenesis, possibly mediated by increased cytokine production causing a chronic inflammatory state. The relationship between obesity, cytokine polymorphisms, and selected mature B-cell neoplasms is reported. Method: Data on 4,979 cases and 4,752 controls from nine American/European studies from the InterLymph consortium (1988–2008) were pooled. For diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), joint associations of body mass index (from self-reported height and weight) and 12 polymorphisms in cytokines IL1A (rs1800587), IL1B (rs16944, rs1143627), IL1RN (rs454078), IL2 (rs2069762), IL6 (rs1800795, rs1800797), IL10 (rs1800890, rs1800896), TNF (rs1800629), LTA (rs909253), and CARD15 (rs2066847) were investigated using unconditional logistic regression. BMI-polymorphism interaction effects were estimated using the relative excess risk due to interaction (RERI). Results: Obesity (BMI ≥ 30 kg/m2) was associated with DLBCL risk [OR = 1.33; 95% confidence interval (CI), 1.02–1.73], as was TNF-308GA+AA (OR = 1.24; 95% CI, 1.07–1.44). Together, being obese and TNF-308GA+AA increased DLBCL risk almost 2-fold relative to those of normal weight and TNF-308GG (OR = 1.93; 95% CI, 1.27–2.94), with a RERI of 0.41 (95% CI, −0.05–0.84; Pinteraction = 0.13). For FL and CLL/SLL, no associations with obesity or TNF-308GA+AA, either singly or jointly, were observed. No evidence of interactions between obesity and the other polymorphisms were detected. Conclusions: Our results suggest that cytokine polymorphisms do not generally interact with BMI to increase lymphoma risk but obesity and TNF-308GA+AA may interact to increase DLBCL risk. Impact: Studies using better measures of adiposity are needed to further investigate the interactions between obesity and TNF-308G&gt;A in the pathogenesis of lymphoma. Cancer Epidemiol Biomarkers Prev; 24(7); 1061–70. ©2015 AACR.
Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk
Permuth‐Wey, Jennifer, Chen, Zhihua , Gayther, Simon A. , Goode, Ellen L. , Iversen, Edwin S. , Pearce, Leigh, Phelan, Catherine M., Pirie, Ailith, Rossing, Mary Ann, Schildkraut, Joellen M. , Sellers, Thomas A. , Chen, Y. Ann , Berchuck, Andrew , Chenevix‐Trench, Georgia , Doherty, Jennifer A. , Monteiro, Álvaro N.A. , Pharoah, Paul D.P. , Ramus, Susan J. , Rossing, Mary Anne

Mayo Clinic

Cancer Research | May 4, 2015 | Volume: 74 | Issue: 19_Supplement | Pages: 946-946

10.1158/1538-7445.am2014-946 Get It

Abstract Background: Common genetic variants identified by genome-wide association studies and follow-up genotyping initiatives only explain a small proportion of the heritability of epithelial ovarian cancer (EOC). We hypothesized that some of the missing heritability may be explained by rare (minor allele frequency (MAF) &lt;0.5%) and low-frequency (MAF 0.5-5%) protein-coding variants that are not well captured by genotyping arrays that focus on common variants. Methods: To examine the association between uncommon variants and EOC susceptibility, we genotyped 7,060 EOC cases and 6,712 controls from the Ovarian Cancer Association Consortium using the Affymetrix Axiom Exome Genotyping Array. This platform contains 300,785 putative functional coding variants selected from exome sequences of 12,000+ individuals representing multiple ethnicities and complex traits. After performing quality control (QC), we used unconditional logistic regression treating the number of minor alleles carried as an ordinal variable (log-additive model) to evaluate SNP-EOC risk associations. Genotype cluster plots were visually inspected for top-ranking variants to determine assay success, and allele frequencies of samples from the 1000 Genomes Project and other cohorts were evaluated for QC purposes. Results: A total of 13,318 samples (97%) passed QC, and 12,779 eligible samples (6,293 invasive serous and endometrioid cases and 6,486 controls) were included in the analyses. 280,737 (93%) of the 300,785 attempted markers were successfully genotyped and had call rates &gt;90%. After removing 31,436 monomorphic markers, the 249,301 remaining markers were included in association analyses. We confirmed variants at previously reported EOC susceptibility loci (9p22, 3q25, 17cen-q21.3, and 8q24), with p-values between 10-5 and 10-11. Several correlated low-frequency non-synonymous variants (MAF=5%) residing in a novel EOC susceptibility gene at 3q25.31 were risk-associated. The most significant variant at 3q25.31 had an OR=1.36 and p = 5.58x10-8. Also noteworthy is a rare variant at 15q15.1-q21.1 (MAF=0.5%) that introduces a stop codon in a gene belonging to the tyrosine kinase family (OR=0.39, CI=0.26-0.58, p = 4.52x10-6). We also identified a more common synonymous coding variant in a phosphatase at 6q21.3 that was associated with increased risk (OR=1.22, CI=1.13-1.33, p = 1.84x10-6, MAF=9.6%). Population stratification and gene-based analyses are underway to further examine the impact of the newly-identified variants on EOC risk. A meta-analysis to include data from an additional 2104 EOC cases and 2516 controls genotyped with Illumina's HumanExome Beadchip rare variant array is also underway. Functional analysis of the most promising variants will follow. Conclusions: Preliminary data from this large-scale study reveals novel rare and low-frequency variants that may influence susceptibility to epithelial ovarian cancer. Citation Format: Jennifer Permuth-Wey, Y. Ann Chen, Zhihua Chen, Andrew Berchuck, Georgia Chenevix-Trench, Jennifer Doherty, Simon Gayther, Ellen L. Goode, Edwin Iversen, Alvaro N.A. Monteiro, Leigh Pearce, Paul D.P. Pharoah, Catherine M. Phelan, Ailith Pirie, Susan Ramus, Mary Ann Rossing, Joellen M. Schildkraut, Thomas A. Sellers, on behalf of the Ovarian Cancer Association Consortium. Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 946. doi:10.1158/1538-7445.AM2014-946